Mutual of America Capital Management LLC Trims Stake in Sotera Health (NASDAQ:SHC)

Mutual of America Capital Management LLC cut its holdings in Sotera Health (NASDAQ:SHC) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 80,794 shares of the company’s stock after selling 1,860 shares during the period. Mutual of America Capital Management LLC’s holdings in Sotera Health were worth $1,105,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Wealth Enhancement Advisory Services LLC boosted its position in shares of Sotera Health by 2.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company’s stock worth $711,000 after purchasing an additional 1,047 shares during the period. GAMMA Investing LLC increased its holdings in Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after acquiring an additional 1,121 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after buying an additional 1,140 shares in the last quarter. New York State Teachers Retirement System lifted its position in Sotera Health by 3.5% during the third quarter. New York State Teachers Retirement System now owns 53,500 shares of the company’s stock valued at $893,000 after purchasing an additional 1,800 shares during the last quarter. Finally, True Wealth Design LLC purchased a new stake in Sotera Health in the third quarter worth $32,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Up 1.0 %

NASDAQ:SHC opened at $12.16 on Monday. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.08. The firm has a market cap of $3.45 billion, a PE ratio of 48.64 and a beta of 1.92. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock has a fifty day moving average price of $13.28 and a 200 day moving average price of $14.39.

Wall Street Analyst Weigh In

SHC has been the topic of several research analyst reports. Barclays dropped their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research note on Friday, February 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Finally, The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 target price for the company. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $15.92.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.